[1]Patent:WO2016/46574,2016,A1.Locationinpatent:Page/Pagecolumn75
Title: Sanderson RJ, et al. In vivo drug-linker stability of an anti-CD30 dipeptide-linked auristatin immunoconjugate. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):843-52.
160800-57-7
474645-27-7
863971-19-1
2070009-72-0
15366-34-4 | Methyl 1H-pyrazole-5-carboxylate | AA003RHM | MFCD00649381
3686-55-3 | Methyl 2-ethoxybenzoate | AA003RKZ | MFCD00017261
91076-93-6 | methyl 3-amino-5-(4-chlorophenyl)thiophene-2-carboxylate | AA003ROG | MFCD00052591
773134-43-3 | Methyl 4-bromo-2-(methylsulfonyl)benzoate | AA003RRX | MFCD06204242
869985-47-7 | Methyl 6-(3-methoxyphenyl)nicotinate | AA003RVF | MFCD08166613
678-18-2 | 1H,1H,1H-NONAFLUORO-2-HEXANONE | AA003RYP | MFCD00153209
142-18-7 | Monolaurin | AA003S2U | MFCD00037815
53-96-3 | N-(9H-Fluoren-2-yl)acetamide | AA003S6L | MFCD00001116
6097-08-1 | N-(5-Hexynyl)phthalimide | AA003SAW | MFCD00671372
42137-88-2 | N,N-Bis(2-chloroethyl)-p-toluenesulfonamide | AA003SEW | MFCD00018944